Fact CheckerSign in

NCT07000903Completed

Occupational and Environmental Causes of Autoimmune Diseases

Occupational and Environmental Causes of Autoimmune Diseases: Clarifying Epidemiology and Improving Detection

Source: ClinicalTrials.gov · Last updated 3 Jun 2025

Brief summary (registry, in English)

The investigators hypothesize that part of the systemic autoimmune diseases (AID) patients might prove to have an occupational or environmental disease which is potentially preventable. The recognition of the occupational or environmental etiology of autoimmune disorders has major implications for patients and society and will generate opportunity for prevention and meaningful clinical intervention. The investigators intend to use the urine/blood exposure measurements to demonstrate the etiological role of environment in patients developing AID patients. The investigators are mounting an epidemiological study to elucidate the environmental etiology of AID and their effects on the immune profile and disease course. A population-based case-control study will be done with adult patients with newly diagnosed systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis (n=100 per disease).

Status (registry)
Completed
Study type
Interventional
Enrollment
247 (actual)
First submitted
20 Jun 2022
Start date
10 May 2022
Primary completion date
5 Apr 2024
Lead sponsor
Université Catholique de Louvain
NCT number
NCT07000903

What you commit to

  • Study type: Interventional
  • Participants enrolled: 247
  • From 10 May 2022 to the primary completion date, 5 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Younger than 18

Other

  • Wearers of metal prostheses

Who the study is looking for

  • Clinically active lupus; systemic sclerosis; rheumatoid arthritis
  • At least 18 years old
  • Without first line disease-modifying therapy
  • Written informed consent must be obtained before any assessment is performed

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cliniques universitaires Saint-Luc
Coordinator of this site? Confirm its status
BrusselsBelgiumUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.